GeraldGKruegerMD

Dermatology • Salt Lake City, UT

Dermatologic Surgery

Professor of Dermatology, University Utah

Join to view full profile

Dr. Krueger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Krueger's full profile

Already have an account?

Office
50 N Medical Dr
Salt Lake City, UT 84132
Phone+1 801-581-2955

Fax+1 801-587-6346

Education & Training

University of ColoradoResidency, Dermatology, 1969 - 1972
Fitzsimons Army Medical CenterInternship, Transitional Year, 1966 - 1967
Loma Linda University School of MedicineClass of 1966

Certifications & Licensure

UT State Medical License 1972 - 2026
NC State Medical License 1968 - 1970
American Board of Dermatology Dermatology

Awards, Honors, & Recognition

Distinguished Professor Department of Dermatology University of Utah, 2017
Most Influential Physician National Psoriasis Foundation at 50th year Gala Event National Psoriasis Foundation, 2017
America's Top Doctors Castle Connolly, 2002-2014
CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
Fellow (FAAD) American Academy of Dermatology
Join now to see all

Clinical Trials

Safety and Efficacy Study of MM-093 in Patients With Chronic Plaque Psoriasis Start of enrollment: 2005 Sep 01
Completed
Phase 2
Efficacy of Ustekinumab Followed by Abatacept for the Treatment of Psoriasis Vulgaris Start of enrollment: 2014 Mar 19
Completed
Phase 2
A Study of Multiple Doses of AbGn-168H by Intravenous Infusion in Patients With Moderate to Severe Chronic Plaque Psoriasis Start of enrollment: 2014 May 01
Completed
Phase 2

Publications & Presentations

PubMed

PAPRIKA: A Question Bank for Assessing Psoriatic Arthritis Risk in Individuals of Diverse Ancestries.
Jessica A Walsh, Courtney Carroll, Kristina Callis Duffin, Jing Wang, Gerald G Krueger
Arthritis Care & Research. 2024-03-01
12 citations
Effect of Costimulatory Blockade With Abatacept After Ustekinumab Withdrawal in Patients With Moderate to Severe Plaque Psoriasis: The PAUSE Randomized Clinical Trial.
Kristina M. Harris, Dawn E. Smilek, Margie Byron, Noha Lim, William T. Barry
JAMA Dermatology. 2021-10-13
7 citations
The Proposed PASI-HD Provides More Precise Assessment of Plaque Psoriasis Severity in Anatomical Regions with a Low Area Score
Kim A. Papp, Mark Lebwohl, Leon H Kircik, David M. Pariser, Bruce Strober
Dermatology and Therapy. 2021-07-08

Journal Articles

Systemic Corticosteroid Use in Psoriasis: A National Survey of Board‐Certified Dermatologists
Aaron M Secrest, Dena M Elkeeb, Ashley Elsensohn, Gerald G Krueger, Journal of The European Academy of Dermatology and Venereology

Press Mentions

Check Your Health: Managing Dry Winter SkinFebruary 21st, 2020
Studying the Genes of People with Psoriasis and Psoriatic Arthritis Offers the Promise of New TreatmentsMay 6th, 2015
Director Emerita of the University of Michigan Transportation ResearchAugust 15th, 2003

Grant Support

Utah Psoriasis InitiativeNational Center For Research Resources2004–2005
Use Of Genetically Modified Skin To Treat DiseaseEunice Kennedy Shriver National Institute Of Child Health &Human Development1992–2003
Dose Response Study Of Bg9273(Lfa 3 &Igg1 Fusion Protein)National Center For Research Resources1999–2002
Approaches To Correct Diseases With Genetically Modified Cells Of The SkinEunice Kennedy Shriver National Institute Of Child Health &Human Development1999–2002
Five Dose Trial Of Abx IL8 In Treatment Of Severe Plaque PsoriasisNational Center For Research Resources1999–2001
Randomized Double Blind Study To Evaluate Biologic Activity Of Bg9273National Center For Research Resources1998–2001
Pilot Study Of The Safety And Eficacy Of ISIS 2302 On PsoriasisNational Center For Research Resources1998–1999
Phase II Randomized Bms 188667 In Patients With Psoriasis VulgarisNational Center For Research Resources1998–1999
Approaches To Correct Diseases With Genetically Modified Cells Of Human SkinEunice Kennedy Shriver National Institute Of Child Health &Human Development1995–1998
OPEN Labeled Pilot Study Of Safety And Efficacy Of ISIS 2302 On PsoriasisNational Center For Research Resources1997
Suppressor T-Cell Manipulation As A Cancer ImmunotherapyNational Cancer Institute1989–1990
Psoriasis: Its Genotype And Pathogenesis: Model SystemNational Institute Of Arthritis And Musculoskeletal And Skin Diseases1986–1988
Evaluation Of Ro-9359 VS Placebo In Patients With Severe PsoriasisNational Center For Research Resources1985
13-CIS Retinoic Acid In Keratinization DisordersNational Center For Research Resources1985
Psoriasis: Its Genotype And Pathogenesis: Model SystemNat Inst Of Arthritis, Diabetes, Digestive &Kidney Diseases1985